Gurinder Singh1, Wei Zhang2, Yong-Fang Kuo3, Gulshan Sharma4. 1. Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Internal Medicine, University of Texas Medical Branch, Galveston, TX. Electronic address: gpsingh@utmb.edu. 2. Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Internal Medicine, University of Texas Medical Branch, Galveston, TX. 3. Office of Biostatistics, University of Texas Medical Branch, Galveston, TX; Sealy Center of Aging, University of Texas Medical Branch, Galveston, TX. 4. Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Internal Medicine, University of Texas Medical Branch, Galveston, TX; Sealy Center of Aging, University of Texas Medical Branch, Galveston, TX.
Abstract
BACKGROUND: There is a growing understanding of the prevalence and impact of psychological disorders on COPD. However, the role of these disorders in early readmission is unclear. METHODS: We analyzed data from 5% fee-for-service Medicare beneficiaries diagnosed with COPD (International Classification of Diseases, Ninth Revision code, 491.xx, 492.xx, 493.xx, and 496.xx) between 2001 and 2011 who were hospitalized with a primary discharge diagnosis of COPD or a primary discharge diagnosis of respiratory failure (518.xx and 799.1) with secondary diagnosis of COPD. We hypothesized that such psychological disorders as depression, anxiety, psychosis, alcohol abuse, and drug abuse are independently associated with an increased risk of 30-day readmission in patients hospitalized for COPD. RESULTS: Between 2001 and 2011, 135,498 hospitalizations occurred for COPD in 80,088 fee-for-service Medicare beneficiaries. Of these, 30,218 (22.30%) patients had one or more psychological disorders. In multivariate analyses, odds of 30-day readmission were higher in patients with COPD who had depression (OR, 1.34; 95% CI, 1.29-1.39), anxiety (OR, 1.43; 95% CI, 1.37-1.50), psychosis (OR, 1.18; 95% CI, 1.10-1.27), alcohol abuse (OR, 1.30; 95% CI, 1.15-1.47), and drug abuse (OR, 1.29; 95% CI, 1.11-1.50) compared with those who did not have these disorders. These psychological disorders increased amount of variation in 30-day readmission attributed to patient characteristics by 37%. CONCLUSIONS: Psychological disorders like depression, anxiety, psychosis, alcohol abuse, and drug abuse are independently associated with higher all-cause 30-day readmission rates for Medicare beneficiaries with COPD.
BACKGROUND: There is a growing understanding of the prevalence and impact of psychological disorders on COPD. However, the role of these disorders in early readmission is unclear. METHODS: We analyzed data from 5% fee-for-service Medicare beneficiaries diagnosed with COPD (International Classification of Diseases, Ninth Revision code, 491.xx, 492.xx, 493.xx, and 496.xx) between 2001 and 2011 who were hospitalized with a primary discharge diagnosis of COPD or a primary discharge diagnosis of respiratory failure (518.xx and 799.1) with secondary diagnosis of COPD. We hypothesized that such psychological disorders as depression, anxiety, psychosis, alcohol abuse, and drug abuse are independently associated with an increased risk of 30-day readmission in patients hospitalized for COPD. RESULTS: Between 2001 and 2011, 135,498 hospitalizations occurred for COPD in 80,088 fee-for-service Medicare beneficiaries. Of these, 30,218 (22.30%) patients had one or more psychological disorders. In multivariate analyses, odds of 30-day readmission were higher in patients with COPD who had depression (OR, 1.34; 95% CI, 1.29-1.39), anxiety (OR, 1.43; 95% CI, 1.37-1.50), psychosis (OR, 1.18; 95% CI, 1.10-1.27), alcohol abuse (OR, 1.30; 95% CI, 1.15-1.47), and drug abuse (OR, 1.29; 95% CI, 1.11-1.50) compared with those who did not have these disorders. These psychological disorders increased amount of variation in 30-day readmission attributed to patient characteristics by 37%. CONCLUSIONS:Psychological disorders like depression, anxiety, psychosis, alcohol abuse, and drug abuse are independently associated with higher all-cause 30-day readmission rates for Medicare beneficiaries with COPD.
Authors: Gregory Luke Larkin; Cynthia A Claassen; Jennifer A Emond; Andrea J Pelletier; Carlos A Camargo Journal: Psychiatr Serv Date: 2005-06 Impact factor: 3.084
Authors: Valentin Prieto-Centurion; Michael A Markos; Norma I Ramey; Hélène A Gussin; Sharmilee M Nyenhuis; Min J Joo; Bharati Prasad; Nina Bracken; Robert Didomenico; Patrick O Godwin; Howard A Jaffe; Ravi Kalhan; Alan S Pickard; Barry R Pittendrigh; Bruce Schatz; Jamie L Sullivan; Byron M Thomashow; Mark V Williams; Jerry A Krishnan Journal: Ann Am Thorac Soc Date: 2014-03
Authors: Vincent S Fan; Scott D Ramsey; Nicholas D Giardino; Barry J Make; Charles F Emery; Phillip T Diaz; Joshua O Benditt; Zab Mosenifar; Robert McKenna; Jeffrey L Curtis; Alfred P Fishman; Fernando J Martinez Journal: Arch Intern Med Date: 2007-11-26
Authors: Tadahiro Goto; Mohammad Kamal Faridi; Koichiro Gibo; Sengwee Toh; Nicola A Hanania; Carlos A Camargo; Kohei Hasegawa Journal: Respir Med Date: 2017-07-26 Impact factor: 3.415
Authors: Stefanie C Vuotto; Kevin R Krull; Chenghong Li; Kevin C Oeffinger; Daniel M Green; Sunita K Patel; Deokumar Srivastava; Marilyn Stovall; Kirsten K Ness; Gregory T Armstrong; Leslie L Robison; Tara M Brinkman Journal: Cancer Date: 2016-10-20 Impact factor: 6.860
Authors: Naomi Launders; Kate Dotsikas; Louise Marston; Gabriele Price; David P J Osborn; Joseph F Hayes Journal: PLoS One Date: 2022-08-18 Impact factor: 3.752
Authors: Kristina L Bailey; Harry Smith; Susan K Mathai; Jonathan Huber; Mark Yacoub; Ivana V Yang; Todd A Wyatt; Katerina Kechris; Ellen L Burnham Journal: Alcohol Clin Exp Res Date: 2020-07-01 Impact factor: 3.455
Authors: Daniel A Puebla Neira; En Shuo Hsu; Yong-Fang Kuo; Kenneth J Ottenbacher; Gulshan Sharma Journal: Am J Respir Crit Care Med Date: 2021-02-15 Impact factor: 21.405